AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹254 Cr | ₹245 Cr | ₹359 Cr | ₹133 Cr | ₹70 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹254 Cr |
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹359 Cr |
| Mar2023 | ₹133 Cr |
| Mar2022 | ₹70 Cr |
How is Cash Flow from Operating Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹254 Cr | 3.66 | |
| Mar2025 | ₹245 Cr | -31.86 | |
| Mar2024 | ₹359 Cr | 169.22 | |
| Mar2023 | ₹133 Cr | 89.34 | |
| Mar2022 | ₹70 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,423.9 Cr | -3.4% | 27.4% | 7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -3.4% |
27.4% |
7.9% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses